Cargando…
Cell-Free DNA–Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial
SIMPLE SUMMARY: NHS-Galleri is a randomised controlled trial that will assess how well a blood test can reduce the number of late-stage cancers by helping to find cancers early. The test looks at patterns in blood samples to detect a cancer signal. NHS-Galleri has enrolled over 140,000 people, invit...
Autores principales: | Neal, Richard D., Johnson, Peter, Clarke, Christina A., Hamilton, Stephanie A., Zhang, Nan, Kumar, Harpal, Swanton, Charles, Sasieni, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564213/ https://www.ncbi.nlm.nih.gov/pubmed/36230741 http://dx.doi.org/10.3390/cancers14194818 |
Ejemplares similares
-
Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri
por: Brentnall, Adam R, et al.
Publicado: (2023) -
Psychological Impact of the Galleri test (sIG(n)al): protocol for a longitudinal evaluation of the psychological impact of receiving a cancer signal in the NHS-Galleri trial
por: Marlow, Laura A V, et al.
Publicado: (2023) -
Modelled mortality benefits of multi-cancer early detection screening in England
por: Sasieni, Peter, et al.
Publicado: (2023) -
An ongoing case-control study to evaluate the NHS breast screening programme
por: Massat, Nathalie J, et al.
Publicado: (2013) -
An ongoing case–control study to evaluate the NHS Bowel Cancer Screening Programme
por: Massat, Nathalie J, et al.
Publicado: (2014)